The Bipartisan Policy Center (BPC) hosted an open discussion on the future of AI on Wednesday, Oct. 16, in Washington, D.C. Topics included AI’s impact on the economy and how public policies may change in the near future as a response to these evolving technologies.

Former Google China President Kai-Fu Lee believes the rise of AI “will come in waves,” he told FOX Business. Lee said healthcare is one of the industries that will benefit the most from AI. 

The FDA has issued a voluntary recall of valsartan, due to concerns of an impurity N-nitrosodimethylamine (NDMA), a known carcinogen, which was found in a batch of the drug manufactured in China. Valsartan is commonly used to control hypertension and heart failure.

Ethicists from the University of Basel have developed a biosecurity framework specific to neurotechnology while calling for a ban on dual-use technology with the aim of regulating mental privacy and integrity of humans. Findings were published in Neuron.

As cyberattack become increasingly common incidents, healthcare professionals must push security to the forefront. In a presentation given at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, Jim Whitfill, CMO of innovation Health Partners and president of Lumetis, described the current cybersecurity environment and detailed how professionals can take steps toward improving privacy.

Despite increased prevention efforts and longer lifespans, heart failure rates are at a high in the United Kingdom and are continuing to climb, according to new research published in The Lancet.

While platforms such as Facebook, Twitter and Instagram give people the ability to connect with anyone in the world, the American Medical Association (AMA) has announced the adoption of new policies outlining the negative health effects of social media.

The U.S. Food and Drug Administration (FDA) has approved the first digital pill with an ingestion tracking system to tell physicians whether patients have taken their medication.